# Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies

> **NCT00423124** · PHASE1,PHASE2 · COMPLETED · sponsor: **AGC Biologics S.p.A.** · enrollment: 57 (actual)

## Conditions studied

- Hematological Malignancies

## Interventions

- **GENETIC:** HSV-TK

## Key facts

- **NCT ID:** NCT00423124
- **Lead sponsor:** AGC Biologics S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2011-12
- **Final completion:** 2013-11
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423124, "Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00423124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*